Indolent Systemic Mastocytosis: A New Era of Treatment

Improve your knowledge of the clinical presentation, diagnosis, and treatment of indolent systemic mastocytosis (ISM) and improve patient outcomes by viewing 2 Medical Minutes, including downloadable slidesets, and 2 ClinicalThoughts with expert commentary on today’s best practices in ISM management.

Share

Program Content

Activities

ISM Diagnosis
Medical Minute 1: Recognizing ISM Differential Diagnosis and Patient Evaluation
Video
Congratulations: You achieved a completion on 04/09/2022

Released: November 09, 2023

Expires: November 08, 2024

View Activity

Activities

Diagnosis
Medical Minute 1: Recognizing ISM Differential Diagnosis and Patient Evaluation
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 09, 2023

View Activity

Activities

ISM Diagnosis
Diagnosis of Indolent Systemic Mastocytosis: What You Need to Know
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 13, 2023

Expires: November 12, 2024

View Activity

Activities

ISM Treatment
Medical Minute 2: Treatment and Management of Indolent Systemic Mastocytosis
Video
Congratulations: You achieved a completion on 04/09/2022

Released: November 10, 2023

Expires: November 09, 2024

View Activity

Activities

ISM Treatment
The Treatment of ISM: An Expert’s Review
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 14, 2023

Expires: November 13, 2024

View Activity

Faculty

cover img faculity

Mariana Castells, MD, PhD

Director, Drug Hypersensitivity and Desensitization Center
Director, Mastocytosis Center
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Tracy George, MD

Professor of Pathology
Spencer Fox Eccles School of Medicine at the University of Utah
President, Innovation Business Unit, and Chief Scientific Officer
ARUP Laboratories
Salt Lake City, UT

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Blueprint Medicines.

Blueprint Medicines